SPOTLIGHT -
FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia
Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
SECO 2023: Orasis Pharmaceuticals presents pipeline update at OIS
Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.